| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/25.2.227 |
| P698 | PubMed publication ID | 2329101 |
| P2093 | author name string | F Meunier | |
| P Van der Auwera | |||
| C Lambert | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluconazole | Q411478 |
| amphotericin B | Q412223 | ||
| P304 | page(s) | 227-236 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazole | |
| P478 | volume | 25 |
| Q41740968 | Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development |
| Q39870923 | Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice |
| Q43886209 | Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2. |
| Q44239576 | Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3. |
| Q40087970 | Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans |
| Q35826590 | In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304 |
| Q41377981 | Key issues concerning fungistatic versus fungicidal drugs |
| Q73615028 | Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans |
| Q39867357 | Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration |
| Q44586157 | Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase |
| Q80264665 | Systemic antifungal agents |
| Q41592981 | Update on antifungal resistance |
Search more.